ISSN:

Journal Home

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Q2 Unclaimed

Dove Medical Press Ltd. New Zealand

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is a journal indexed in SJR in Pharmacology and Internal Medicine with an H index of 57. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1762,2 €. The scope of the journal is focused on diabetes, obesity, metabolic syndrome. It has an SJR impact factor of 0,851 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,851.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Internal Medicine (Q2) Pharmacology (Q2)

Price

1762,2 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

0,851

SJR Impact factor

57

H Index

343

Total Docs (Last Year)

1168

Total Docs (3 years)

15681

Total Refs

4336

Total Cites (3 years)

1157

Citable Docs (3 years)

3.35

Cites/Doc (2 years)

45.72

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Drug Safety - Case Reports Q2
Biomarker Insights Q2
Expert Review of Anticancer Therapy Q2
American Journal of Cardiovascular Drugs Q2
Infection and Drug Resistance Q2

Compare this journals

Aims and Scope

Diabetes Obesity Metabolic syndrome